APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Prothrombin Complex Concentrate

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Human Prothrombin Complex Concentrate Market Outlook and Growth Opportunities 2026

22 December 2025193 pages

Choose your research edition.

Industry ResearchHuman Prothrombin Complex Concentrate Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Prothrombin Complex Concentrate Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Human Prothrombin Complex Concentrate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Prothrombin Complex Concentrate Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Prothrombin Complex Concentrate Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Human Prothrombin Complex Concentrate market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Human Prothrombin Complex Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Human Prothrombin Complex Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Prothrombin Complex Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Human Prothrombin Complex Concentrate market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Human Prothrombin Complex Concentrate market include Takeda, Weiguang Biology, Thailand Bio, Shanghai Emerging Pharmaceuticals, Shanghai RAAS, Green Cross (China) Biological Products Co., Ltd., Jiangxi Boya Biopharmaceutical Co., Ltd., Hualan Bio and Guangdong Shuanglin Biopharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Human Prothrombin Complex Concentrate market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Human Prothrombin Complex Concentrate and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Human Prothrombin Complex Concentrate sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Human Prothrombin Complex Concentrate market size, projected growth trends, production technologies, key applications, and end-use industries.

Human Prothrombin Complex Concentrate Segment by Company

Takeda

Weiguang Biology

Thailand Bio

Shanghai Emerging Pharmaceuticals

Shanghai RAAS

Green Cross (China) Biological Products Co., Ltd.

Jiangxi Boya Biopharmaceutical Co., Ltd.

Hualan Bio

Guangdong Shuanglin Biopharmaceutical Co., Ltd.

Beijing Tiantan Biological Products Co., Ltd.

Beijing Bohui Innovative Biotechnology Group Co., Ltd.

Octapharma

Grifols

CSL

Biotest

Human Prothrombin Complex Concentrate Segment by Type

500 IU

1000 IU

Human Prothrombin Complex Concentrate Segment by Application

Hemophilia B

Vitamin K Deficiency

Other

Human Prothrombin Complex Concentrate Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Human Prothrombin Complex Concentrate status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Human Prothrombin Complex Concentrate market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Human Prothrombin Complex Concentrate significant trends, drivers, influence factors in global and regions.

6. To analyze Human Prothrombin Complex Concentrate competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Prothrombin Complex Concentrate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Prothrombin Complex Concentrate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Prothrombin Complex Concentrate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Human Prothrombin Complex Concentrate market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Human Prothrombin Complex Concentrate industry.

Chapter 3: Detailed analysis of Human Prothrombin Complex Concentrate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Human Prothrombin Complex Concentrate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Human Prothrombin Complex Concentrate in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Human Prothrombin Complex Concentrate Industry Trends Table 2. Human Prothrombin Complex Concentrate Industry Drivers Table 3. Human Prothrombin Complex Concentrate Industry Opportunities and Challenges Table 4. Human Prothrombin Complex Concentrate Industry Restraints Table 5. Global Human Prothrombin Complex Concentrate Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Human Prothrombin Complex Concentrate Revenue Share by Company (2021-2026) Table 7. Global Human Prothrombin Complex Concentrate Sales Volume by Company (k units) & (2021-2026) Table 8. Global Human Prothrombin Complex Concentrate Sales Volume Share by Company (2021-2026) Table 9. Global Human Prothrombin Complex Concentrate Average Price (US$/unit) of Company (2021-2026) Table 10. Global Human Prothrombin Complex Concentrate Company Ranking, (2024-2026) & (USD Million) Table 11. Global Human Prothrombin Complex Concentrate Key Company Manufacturing Base & Headquarters Table 12. Global Human Prothrombin Complex Concentrate Company, Product Type & Application Table 13. Global Human Prothrombin Complex Concentrate Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Human Prothrombin Complex Concentrate by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 500 IU Table 18. Significant Companies of 1000 IU Table 19. Global Human Prothrombin Complex Concentrate Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Human Prothrombin Complex Concentrate Sales Volume by Type (2021-2026) & (k units) Table 21. Global Human Prothrombin Complex Concentrate Sales Volume by Type (2027-2032) & (k units) Table 22. Global Human Prothrombin Complex Concentrate Sales Volume Share by Type (2021-2026) Table 23. Global Human Prothrombin Complex Concentrate Sales Volume Share by Type (2027-2032) Table 24. Global Human Prothrombin Complex Concentrate Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Human Prothrombin Complex Concentrate Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Human Prothrombin Complex Concentrate Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Human Prothrombin Complex Concentrate Sales Value Share by Type (2021-2026) Table 28. Global Human Prothrombin Complex Concentrate Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hemophilia B Table 30. Significant Companies of Vitamin K Deficiency Table 31. Significant Companies of Other Table 32. Global Human Prothrombin Complex Concentrate Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Human Prothrombin Complex Concentrate Sales Volume by Application (2021-2026) & (k units) Table 34. Global Human Prothrombin Complex Concentrate Sales Volume by Application (2027-2032) & (k units) Table 35. Global Human Prothrombin Complex Concentrate Sales Volume Share by Application (2021-2026) Table 36. Global Human Prothrombin Complex Concentrate Sales Volume Share by Application (2027-2032) Table 37. Global Human Prothrombin Complex Concentrate Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Human Prothrombin Complex Concentrate Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Human Prothrombin Complex Concentrate Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Human Prothrombin Complex Concentrate Sales Value Share by Application (2021-2026) Table 41. Global Human Prothrombin Complex Concentrate Sales Value Share by Application (2027-2032) Table 42. Global Human Prothrombin Complex Concentrate Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Human Prothrombin Complex Concentrate Sales by Region (2021-2026) & (k units) Table 44. Global Human Prothrombin Complex Concentrate Sales Market Share by Region (2021-2026) Table 45. Global Human Prothrombin Complex Concentrate Sales by Region (2027-2032) & (k units) Table 46. Global Human Prothrombin Complex Concentrate Sales Market Share by Region (2027-2032) Table 47. Global Human Prothrombin Complex Concentrate Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Human Prothrombin Complex Concentrate Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Human Prothrombin Complex Concentrate Sales Value Share by Region (2021-2026) Table 50. Global Human Prothrombin Complex Concentrate Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Human Prothrombin Complex Concentrate Sales Value Share by Region (2027-2032) Table 52. Global Human Prothrombin Complex Concentrate Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Human Prothrombin Complex Concentrate Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Human Prothrombin Complex Concentrate Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Human Prothrombin Complex Concentrate Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Human Prothrombin Complex Concentrate Sales by Country (2021-2026) & (k units) Table 57. Global Human Prothrombin Complex Concentrate Sales Market Share by Country (2021-2026) Table 58. Global Human Prothrombin Complex Concentrate Sales by Country (2027-2032) & (k units) Table 59. Global Human Prothrombin Complex Concentrate Sales Market Share by Country (2027-2032) Table 60. Global Human Prothrombin Complex Concentrate Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Human Prothrombin Complex Concentrate Sales Value Market Share by Country (2021-2026) Table 62. Global Human Prothrombin Complex Concentrate Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Human Prothrombin Complex Concentrate Sales Value Market Share by Country (2027-2032) Table 64. Takeda Company Information Table 65. Takeda Business Overview Table 66. Takeda Human Prothrombin Complex Concentrate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Takeda Human Prothrombin Complex Concentrate Product Portfolio Table 68. Takeda Recent Development Table 69. Weiguang Biology Company Information Table 70. Weiguang Biology Business Overview Table 71. Weiguang Biology Human Prothrombin Complex Concentrate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Weiguang Biology Human Prothrombin Complex Concentrate Product Portfolio Table 73. Weiguang Biology Recent Development Table 74. Thailand Bio Company Information Table 75. Thailand Bio Business Overview Table 76. Thailand Bio Human Prothrombin Complex Concentrate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Thailand Bio Human Prothrombin Complex Concentrate Product Portfolio Table 78. Thailand Bio Recent Development Table 79. Shanghai Emerging Pharmaceuticals Company Information Table 80. Shanghai Emerging Pharmaceuticals Business Overview Table 81. Shanghai Emerging Pharmaceuticals Human Prothrombin Complex Concentrate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Shanghai Emerging Pharmaceuticals Human Prothrombin Complex Concentrate Product Portfolio Table 83. Shanghai Emerging Pharmaceuticals Recent Development Table 84. Shanghai RAAS Company Information Table 85. Shanghai RAAS Business Overview Table 86. Shanghai RAAS Human Prothrombin Complex Concentrate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Shanghai RAAS Human Prothrombin Complex Concentrate Product Portfolio Table 88. Shanghai RAAS Recent Development Table 89. Green Cross (China) Biological Products Co., Ltd. Company Information Table 90. Green Cross (China) Biological Products Co., Ltd. Business Overview Table 91. Green Cross (China) Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Green Cross (China) Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio Table 93. Green Cross (China) Biological Products Co., Ltd. Recent Development Table 94. Jiangxi Boya Biopharmaceutical Co., Ltd. Company Information Table 95. Jiangxi Boya Biopharmaceutical Co., Ltd. Business Overview Table 96. Jiangxi Boya Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Jiangxi Boya Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio Table 98. Jiangxi Boya Biopharmaceutical Co., Ltd. Recent Development Table 99. Hualan Bio Company Information Table 100. Hualan Bio Business Overview Table 101. Hualan Bio Human Prothrombin Complex Concentrate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Hualan Bio Human Prothrombin Complex Concentrate Product Portfolio Table 103. Hualan Bio Recent Development Table 104. Guangdong Shuanglin Biopharmaceutical Co., Ltd. Company Information Table 105. Guangdong Shuanglin Biopharmaceutical Co., Ltd. Business Overview Table 106. Guangdong Shuanglin Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Guangdong Shuanglin Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio Table 108. Guangdong Shuanglin Biopharmaceutical Co., Ltd. Recent Development Table 109. Beijing Tiantan Biological Products Co., Ltd. Company Information Table 110. Beijing Tiantan Biological Products Co., Ltd. Business Overview Table 111. Beijing Tiantan Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Beijing Tiantan Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio Table 113. Beijing Tiantan Biological Products Co., Ltd. Recent Development Table 114. Beijing Bohui Innovative Biotechnology Group Co., Ltd. Company Information Table 115. Beijing Bohui Innovative Biotechnology Group Co., Ltd. Business Overview Table 116. Beijing Bohui Innovative Biotechnology Group Co., Ltd. Human Prothrombin Complex Concentrate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Beijing Bohui Innovative Biotechnology Group Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio Table 118. Beijing Bohui Innovative Biotechnology Group Co., Ltd. Recent Development Table 119. Octapharma Company Information Table 120. Octapharma Business Overview Table 121. Octapharma Human Prothrombin Complex Concentrate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. Octapharma Human Prothrombin Complex Concentrate Product Portfolio Table 123. Octapharma Recent Development Table 124. Grifols Company Information Table 125. Grifols Business Overview Table 126. Grifols Human Prothrombin Complex Concentrate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 127. Grifols Human Prothrombin Complex Concentrate Product Portfolio Table 128. Grifols Recent Development Table 129. CSL Company Information Table 130. CSL Business Overview Table 131. CSL Human Prothrombin Complex Concentrate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 132. CSL Human Prothrombin Complex Concentrate Product Portfolio Table 133. CSL Recent Development Table 134. Biotest Company Information Table 135. Biotest Business Overview Table 136. Biotest Human Prothrombin Complex Concentrate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 137. Biotest Human Prothrombin Complex Concentrate Product Portfolio Table 138. Biotest Recent Development Table 139. Key Raw Materials Table 140. Raw Materials Key Suppliers Table 141. Human Prothrombin Complex Concentrate Distributors List Table 142. Human Prothrombin Complex Concentrate Customers List Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Human Prothrombin Complex Concentrate Product Image Figure 2. Global Human Prothrombin Complex Concentrate Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Prothrombin Complex Concentrate Sales Value (2021-2032) & (US$ Million) Figure 4. Global Human Prothrombin Complex Concentrate Sales (2021-2032) & (k units) Figure 5. Global Human Prothrombin Complex Concentrate Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Human Prothrombin Complex Concentrate Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 500 IU Image Figure 10. 1000 IU Image Figure 11. Global Human Prothrombin Complex Concentrate Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Human Prothrombin Complex Concentrate Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Human Prothrombin Complex Concentrate Sales Volume Share by Type (2021-2032) Figure 14. Global Human Prothrombin Complex Concentrate Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Human Prothrombin Complex Concentrate Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Human Prothrombin Complex Concentrate Sales Value Share by Type (2021-2032) Figure 17. Hemophilia B Image Figure 18. Vitamin K Deficiency Image Figure 19. Other Image Figure 20. Global Human Prothrombin Complex Concentrate Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Human Prothrombin Complex Concentrate Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Human Prothrombin Complex Concentrate Sales Volume Share by Application (2021-2032) Figure 23. Global Human Prothrombin Complex Concentrate Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Human Prothrombin Complex Concentrate Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Human Prothrombin Complex Concentrate Sales Value Share by Application (2021-2032) Figure 26. Global Human Prothrombin Complex Concentrate Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Human Prothrombin Complex Concentrate Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Human Prothrombin Complex Concentrate Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Human Prothrombin Complex Concentrate Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Human Prothrombin Complex Concentrate Sales Value (2021-2032) & (US$ Million) Figure 31. North America Human Prothrombin Complex Concentrate Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Human Prothrombin Complex Concentrate Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Human Prothrombin Complex Concentrate Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Human Prothrombin Complex Concentrate Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Human Prothrombin Complex Concentrate Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Human Prothrombin Complex Concentrate Sales Value (2021-2032) & (US$ Million) Figure 37. South America Human Prothrombin Complex Concentrate Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Human Prothrombin Complex Concentrate Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Human Prothrombin Complex Concentrate Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Human Prothrombin Complex Concentrate Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Human Prothrombin Complex Concentrate Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 500 IU
  • 1000 IU
Applications
  • Hemophilia B
  • Vitamin K Deficiency
  • Other
Companies covered
  • Takeda
  • Weiguang Biology
  • Thailand Bio
  • Shanghai Emerging Pharmaceuticals
  • Shanghai RAAS
  • Green Cross (China) Biological Products Co., Ltd.
  • Jiangxi Boya Biopharmaceutical Co., Ltd.
  • Hualan Bio
  • Guangdong Shuanglin Biopharmaceutical Co., Ltd.
  • Beijing Tiantan Biological Products Co., Ltd.
  • Beijing Bohui Innovative Biotechnology Group Co., Ltd.
  • Octapharma
  • Grifols
  • CSL
  • Biotest

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Human Prothrombin Complex Concentrate Sales Value (2021-2032)
  4. 1.2.2 Global Human Prothrombin Complex Concentrate Sales Volume (2021-2032)
  5. 1.2.3 Global Human Prothrombin Complex Concentrate Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Human Prothrombin Complex Concentrate Market Dynamics
  1. 2.1 Human Prothrombin Complex Concentrate Industry Trends
  2. 2.2 Human Prothrombin Complex Concentrate Industry Drivers
  3. 2.3 Human Prothrombin Complex Concentrate Industry Opportunities and Challenges
  4. 2.4 Human Prothrombin Complex Concentrate Industry Restraints
3 Human Prothrombin Complex Concentrate Market by Company
  1. 3.1 Global Human Prothrombin Complex Concentrate Company Revenue Ranking in 2025
  2. 3.2 Global Human Prothrombin Complex Concentrate Revenue by Company (2021-2026)
  3. 3.3 Global Human Prothrombin Complex Concentrate Sales Volume by Company (2021-2026)
  4. 3.4 Global Human Prothrombin Complex Concentrate Average Price by Company (2021-2026)
  5. 3.5 Global Human Prothrombin Complex Concentrate Company Ranking (2024-2026)
  6. 3.6 Global Human Prothrombin Complex Concentrate Company Manufacturing Base and Headquarters
  7. 3.7 Global Human Prothrombin Complex Concentrate Company Product Type and Application
  8. 3.8 Global Human Prothrombin Complex Concentrate Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Human Prothrombin Complex Concentrate Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Human Prothrombin Complex Concentrate Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Human Prothrombin Complex Concentrate Market by Type
  1. 4.1 Human Prothrombin Complex Concentrate Type Introduction
  2. 4.1.1 500 IU
  3. 4.1.2 1000 IU
  4. 4.2 Global Human Prothrombin Complex Concentrate Sales Volume by Type
  5. 4.2.1 Global Human Prothrombin Complex Concentrate Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Human Prothrombin Complex Concentrate Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Human Prothrombin Complex Concentrate Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Human Prothrombin Complex Concentrate Sales Value by Type
  9. 4.3.1 Global Human Prothrombin Complex Concentrate Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Human Prothrombin Complex Concentrate Sales Value by Type (2021-2032)
  11. 4.3.3 Global Human Prothrombin Complex Concentrate Sales Value Share by Type (2021-2032)
5 Human Prothrombin Complex Concentrate Market by Application
  1. 5.1 Human Prothrombin Complex Concentrate Application Introduction
  2. 5.1.1 Hemophilia B
  3. 5.1.2 Vitamin K Deficiency
  4. 5.1.3 Other
  5. 5.2 Global Human Prothrombin Complex Concentrate Sales Volume by Application
  6. 5.2.1 Global Human Prothrombin Complex Concentrate Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Human Prothrombin Complex Concentrate Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Human Prothrombin Complex Concentrate Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Human Prothrombin Complex Concentrate Sales Value by Application
  10. 5.3.1 Global Human Prothrombin Complex Concentrate Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Human Prothrombin Complex Concentrate Sales Value by Application (2021-2032)
  12. 5.3.3 Global Human Prothrombin Complex Concentrate Sales Value Share by Application (2021-2032)
6 Human Prothrombin Complex Concentrate Regional Sales and Value Analysis
  1. 6.1 Global Human Prothrombin Complex Concentrate Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Human Prothrombin Complex Concentrate Sales by Region (2021-2032)
  3. 6.2.1 Global Human Prothrombin Complex Concentrate Sales by Region: 2021-2026
  4. 6.2.2 Global Human Prothrombin Complex Concentrate Sales by Region (2027-2032)
  5. 6.3 Global Human Prothrombin Complex Concentrate Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Human Prothrombin Complex Concentrate Sales Value by Region (2021-2032)
  7. 6.4.1 Global Human Prothrombin Complex Concentrate Sales Value by Region: 2021-2026
  8. 6.4.2 Global Human Prothrombin Complex Concentrate Sales Value by Region (2027-2032)
  9. 6.5 Global Human Prothrombin Complex Concentrate Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Human Prothrombin Complex Concentrate Sales Value (2021-2032)
  12. 6.6.2 North America Human Prothrombin Complex Concentrate Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Human Prothrombin Complex Concentrate Sales Value (2021-2032)
  15. 6.7.2 Europe Human Prothrombin Complex Concentrate Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Human Prothrombin Complex Concentrate Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Human Prothrombin Complex Concentrate Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Human Prothrombin Complex Concentrate Sales Value (2021-2032)
  21. 6.9.2 South America Human Prothrombin Complex Concentrate Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Human Prothrombin Complex Concentrate Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Human Prothrombin Complex Concentrate Sales Value Share by Country, 2025 VS 2032
7 Human Prothrombin Complex Concentrate Country-level Sales and Value Analysis
  1. 7.1 Global Human Prothrombin Complex Concentrate Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Human Prothrombin Complex Concentrate Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Human Prothrombin Complex Concentrate Sales by Country (2021-2032)
  4. 7.3.1 Global Human Prothrombin Complex Concentrate Sales by Country (2021-2026)
  5. 7.3.2 Global Human Prothrombin Complex Concentrate Sales by Country (2027-2032)
  6. 7.4 Global Human Prothrombin Complex Concentrate Sales Value by Country (2021-2032)
  7. 7.4.1 Global Human Prothrombin Complex Concentrate Sales Value by Country (2021-2026)
  8. 7.4.2 Global Human Prothrombin Complex Concentrate Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Human Prothrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Human Prothrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Human Prothrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda Human Prothrombin Complex Concentrate Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Human Prothrombin Complex Concentrate Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 Weiguang Biology
  8. 8.2.1 Weiguang Biology Company Information
  9. 8.2.2 Weiguang Biology Business Overview
  10. 8.2.3 Weiguang Biology Human Prothrombin Complex Concentrate Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Weiguang Biology Human Prothrombin Complex Concentrate Product Portfolio
  12. 8.2.5 Weiguang Biology Recent Developments
  13. 8.3 Thailand Bio
  14. 8.3.1 Thailand Bio Company Information
  15. 8.3.2 Thailand Bio Business Overview
  16. 8.3.3 Thailand Bio Human Prothrombin Complex Concentrate Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Thailand Bio Human Prothrombin Complex Concentrate Product Portfolio
  18. 8.3.5 Thailand Bio Recent Developments
  19. 8.4 Shanghai Emerging Pharmaceuticals
  20. 8.4.1 Shanghai Emerging Pharmaceuticals Company Information
  21. 8.4.2 Shanghai Emerging Pharmaceuticals Business Overview
  22. 8.4.3 Shanghai Emerging Pharmaceuticals Human Prothrombin Complex Concentrate Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Shanghai Emerging Pharmaceuticals Human Prothrombin Complex Concentrate Product Portfolio
  24. 8.4.5 Shanghai Emerging Pharmaceuticals Recent Developments
  25. 8.5 Shanghai RAAS
  26. 8.5.1 Shanghai RAAS Company Information
  27. 8.5.2 Shanghai RAAS Business Overview
  28. 8.5.3 Shanghai RAAS Human Prothrombin Complex Concentrate Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Shanghai RAAS Human Prothrombin Complex Concentrate Product Portfolio
  30. 8.5.5 Shanghai RAAS Recent Developments
  31. 8.6 Green Cross (China) Biological Products Co., Ltd.
  32. 8.6.1 Green Cross (China) Biological Products Co., Ltd. Company Information
  33. 8.6.2 Green Cross (China) Biological Products Co., Ltd. Business Overview
  34. 8.6.3 Green Cross (China) Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Green Cross (China) Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio
  36. 8.6.5 Green Cross (China) Biological Products Co., Ltd. Recent Developments
  37. 8.7 Jiangxi Boya Biopharmaceutical Co., Ltd.
  38. 8.7.1 Jiangxi Boya Biopharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Jiangxi Boya Biopharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Jiangxi Boya Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Jiangxi Boya Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio
  42. 8.7.5 Jiangxi Boya Biopharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Hualan Bio
  44. 8.8.1 Hualan Bio Company Information
  45. 8.8.2 Hualan Bio Business Overview
  46. 8.8.3 Hualan Bio Human Prothrombin Complex Concentrate Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Hualan Bio Human Prothrombin Complex Concentrate Product Portfolio
  48. 8.8.5 Hualan Bio Recent Developments
  49. 8.9 Guangdong Shuanglin Biopharmaceutical Co., Ltd.
  50. 8.9.1 Guangdong Shuanglin Biopharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Guangdong Shuanglin Biopharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Guangdong Shuanglin Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Guangdong Shuanglin Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio
  54. 8.9.5 Guangdong Shuanglin Biopharmaceutical Co., Ltd. Recent Developments
  55. 8.10 Beijing Tiantan Biological Products Co., Ltd.
  56. 8.10.1 Beijing Tiantan Biological Products Co., Ltd. Company Information
  57. 8.10.2 Beijing Tiantan Biological Products Co., Ltd. Business Overview
  58. 8.10.3 Beijing Tiantan Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Beijing Tiantan Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio
  60. 8.10.5 Beijing Tiantan Biological Products Co., Ltd. Recent Developments
  61. 8.11 Beijing Bohui Innovative Biotechnology Group Co., Ltd.
  62. 8.11.1 Beijing Bohui Innovative Biotechnology Group Co., Ltd. Company Information
  63. 8.11.2 Beijing Bohui Innovative Biotechnology Group Co., Ltd. Business Overview
  64. 8.11.3 Beijing Bohui Innovative Biotechnology Group Co., Ltd. Human Prothrombin Complex Concentrate Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Beijing Bohui Innovative Biotechnology Group Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio
  66. 8.11.5 Beijing Bohui Innovative Biotechnology Group Co., Ltd. Recent Developments
  67. 8.12 Octapharma
  68. 8.12.1 Octapharma Company Information
  69. 8.12.2 Octapharma Business Overview
  70. 8.12.3 Octapharma Human Prothrombin Complex Concentrate Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Octapharma Human Prothrombin Complex Concentrate Product Portfolio
  72. 8.12.5 Octapharma Recent Developments
  73. 8.13 Grifols
  74. 8.13.1 Grifols Company Information
  75. 8.13.2 Grifols Business Overview
  76. 8.13.3 Grifols Human Prothrombin Complex Concentrate Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Grifols Human Prothrombin Complex Concentrate Product Portfolio
  78. 8.13.5 Grifols Recent Developments
  79. 8.14 CSL
  80. 8.14.1 CSL Company Information
  81. 8.14.2 CSL Business Overview
  82. 8.14.3 CSL Human Prothrombin Complex Concentrate Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 CSL Human Prothrombin Complex Concentrate Product Portfolio
  84. 8.14.5 CSL Recent Developments
  85. 8.15 Biotest
  86. 8.15.1 Biotest Company Information
  87. 8.15.2 Biotest Business Overview
  88. 8.15.3 Biotest Human Prothrombin Complex Concentrate Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Biotest Human Prothrombin Complex Concentrate Product Portfolio
  90. 8.15.5 Biotest Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Human Prothrombin Complex Concentrate Value Chain Analysis
  2. 9.1.1 Human Prothrombin Complex Concentrate Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Human Prothrombin Complex Concentrate Sales Mode & Process
  6. 9.2 Human Prothrombin Complex Concentrate Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Human Prothrombin Complex Concentrate Distributors
  9. 9.2.3 Human Prothrombin Complex Concentrate Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst